-
1
-
-
73049130173
-
Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro
-
J. Crabbe Stimulation of active sodium transport by the isolated toad bladder with aldosterone in vitro J Clin Invest 40 1961 2103 2106
-
(1961)
J Clin Invest
, vol.40
, pp. 2103-2106
-
-
Crabbe, J.1
-
2
-
-
0030814350
-
Aldosterone, salt and cardiac fibrosis
-
J.W. Funder Aldosterone, salt and cardiac fibrosis Clin Exp Hypertens 19 1997 885 899
-
(1997)
Clin Exp Hypertens
, vol.19
, pp. 885-899
-
-
Funder, J.W.1
-
3
-
-
0030737574
-
Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro
-
A. Sato, J.P. Liu, J.W. Funder Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro Endocrinology 138 1997 3410 3416
-
(1997)
Endocrinology
, vol.138
, pp. 3410-3416
-
-
Sato, A.1
Liu, J.P.2
Funder, J.W.3
-
4
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
-
Randomized Aldactone Evaluation Study J.
-
B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes Randomized Aldactone Evaluation Study The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes8
-
5
-
-
0037417252
-
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
-
Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators M.
-
B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, M. Gatlin Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
-
(2003)
N Engl J Med
, vol.348
, pp. 1309-1321
-
-
Pitt, B.1
Remme, W.2
Zannad, F.3
Neaton, J.4
Martinez, F.5
Roniker, B.6
Bittman, R.7
Hurley, S.8
Kleiman, J.9
Gatlin10
-
6
-
-
0141617520
-
Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy
-
A. Sato, T. Saruta Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy Am J Hypertens 16 2003 781 788
-
(2003)
Am J Hypertens
, vol.16
, pp. 781-788
-
-
Sato, A.1
Saruta, T.2
-
7
-
-
0035022922
-
Aldosterone and the hypertensive kidney: Its emerging role as a mediator of progressive renal dysfunction: A paradigm shift
-
M. Epstein Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift J Hypertens 19 2001 829 842
-
(2001)
J Hypertens
, vol.19
, pp. 829-842
-
-
Epstein, M.1
-
8
-
-
0141730383
-
Aldosterone receptor blockade and the role of eplerenone: Evolving perspectives
-
M. Epstein Aldosterone receptor blockade and the role of eplerenone evolving perspectives Nephrol Dial Transplant 18 2003 1984 1992
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1984-1992
-
-
Epstein, M.1
-
9
-
-
0033745021
-
Aldosterone: A mediator of myocardial necrosis and renal arteriopathy
-
R. Rocha, C.T. Stier Jr, I. Kifor, M.R. Ochoa-maya, H.G. Rennke, G.H. Williams, G.K. Adler Aldosterone a mediator of myocardial necrosis and renal arteriopathy Endocrinology 141 2000 3871 3878
-
(2000)
Endocrinology
, vol.141
, pp. 3871-3878
-
-
Rocha, R.1
Stier Jr., C.T.2
Kifor, I.3
Ochoa-Maya, M.R.4
Rennke, H.G.5
Williams, G.H.6
Adler, G.K.7
-
10
-
-
0034119204
-
Local angiotensin II and transforming growth factor-beta 1 in renal fibrosis of rats
-
Y. Sun, J. Zhang, J.Q. Zhang, F.J. Ramires Local angiotensin II and transforming growth factor-beta 1 in renal fibrosis of rats Hypertension 35 2000 1078 1084
-
(2000)
Hypertension
, vol.35
, pp. 1078-1084
-
-
Sun, Y.1
Zhang, J.2
Zhang, J.Q.3
Ramires, F.J.4
-
11
-
-
0242366540
-
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
-
E.R. Blasi, R. Rocha, A.E. Rudolph, E.A.G. Blomme, M.L. Polly, E.G. McMahon Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats Kidney Int 63 2003 1791 1800
-
(2003)
Kidney Int
, vol.63
, pp. 1791-1800
-
-
Blasi, E.R.1
Rocha, R.2
Rudolph, A.E.3
Blomme, E.A.G.4
Polly, M.L.5
McMahon, E.G.6
-
12
-
-
0037222490
-
Effectiveness of aldosterone blockade in patients with diabetic nephropathy
-
A. Sato, K. Hayashi, M. Naruse, T. Saruta Effectiveness of aldosterone blockade in patients with diabetic nephropathy Hypertension 41 2003 64 68
-
(2003)
Hypertension
, vol.41
, pp. 64-68
-
-
Sato, A.1
Hayashi, K.2
Naruse, M.3
Saruta, T.4
-
13
-
-
0034745049
-
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy
-
A. Sato, T. Saruta Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy J Int Med Res 29 2001 13 21
-
(2001)
J Int Med Res
, vol.29
, pp. 13-21
-
-
Sato, A.1
Saruta, T.2
-
14
-
-
0032951417
-
Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension
-
A. Sato, Y. Suzuki, T. Saruta Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension Hypertens Res 22 1999 17 27
-
(1999)
Hypertens Res
, vol.22
, pp. 17-27
-
-
Sato, A.1
Suzuki, Y.2
Saruta, T.3
-
15
-
-
0027517659
-
The effect of angiotensin-conveting-enzyme inhibition on diabetic nephropathy
-
Collaborative Study Group R.D.
-
E.J. Lewis, L.G. Hunsicker, R.P. Bain, R.D. Rohd Collaborative Study Group The effect of angiotensin-conveting-enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
-
(1993)
N Engl J Med
, vol.329
, pp. 1456-1462
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Bain, R.P.3
Rohd4
-
16
-
-
0034700790
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
-
Heart Outcome Prevention Evaluation (HOPE) Study Investigators
-
Heart Outcome Prevention Evaluation (HOPE) Study Investigators Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy Lancet 355 2000 253 259
-
(2000)
Lancet
, vol.355
, pp. 253-259
-
-
-
17
-
-
0030604561
-
Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
-
The GISEN Group
-
The GISEN Group Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1863
-
(1997)
Lancet
, vol.349
, pp. 1857-1863
-
-
-
18
-
-
15844368318
-
Effect of the angiotensin-conveting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
-
The Angiotensin-Converting-Enzyme Inhibitor in Progressive Renal Insufficiency Study Group P.
-
G. Maschio, D. Alberti, G. Janin, F. Locatelli, J.F. Mann, M. Motolese, C. Ponticelli, E. Ritz, P. Zucchelli The Angiotensin-Converting-Enzyme Inhibitor in Progressive Renal Insufficiency Study Group Effect of the angiotensin-conveting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
-
(1996)
N Engl J Med
, vol.334
, pp. 939-945
-
-
Maschio, G.1
Alberti, D.2
Janin, G.3
Locatelli, F.4
Mann, J.F.5
Motolese, M.6
Ponticelli, C.7
Ritz, E.8
Zucchelli9
-
19
-
-
0035124068
-
Late escape from the antiproteinuric effect of ACE inhibitors in nondiabetic renal disease
-
T. Shiigai, M. Shichiri Late escape from the antiproteinuric effect of ACE inhibitors in nondiabetic renal disease Am J Kidney Dis 37 2001 477 483
-
(2001)
Am J Kidney Dis
, vol.37
, pp. 477-483
-
-
Shiigai, T.1
Shichiri, M.2
-
20
-
-
0036314951
-
Aldosterone breakthrough during angitensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats
-
M. Naruse, A. Tanabe, A. Sato, S. Takagi, K. Tsuchiya, T. Imaki, K. Takano Aldosterone breakthrough during angitensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats Hypertension 40 2002 28 33
-
(2002)
Hypertension
, vol.40
, pp. 28-33
-
-
Naruse, M.1
Tanabe, A.2
Sato, A.3
Takagi, S.4
Tsuchiya, K.5
Imaki, T.6
Takano, K.7
-
21
-
-
0037431774
-
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): A randomized controlled trial
-
N. Nakao, A. Yoshimura, H. Morita, M. Takada, T. Kayano, T. Ideura Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE) a randomized controlled trial Lancet 361 2003 117 124
-
(2003)
Lancet
, vol.361
, pp. 117-124
-
-
Nakao, N.1
Yoshimura, A.2
Morita, H.3
Takada, M.4
Kayano, T.5
Ideura, T.6
-
22
-
-
0029762716
-
High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes
-
A. Sato, J.W. Funder High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes Endocrinology 137 1996 4145 4153
-
(1996)
Endocrinology
, vol.137
, pp. 4145-4153
-
-
Sato, A.1
Funder, J.W.2
-
23
-
-
0041318968
-
Nongenomic vascular action of aldosterone in the glomerular microcirculation
-
S. Arima, K. Kohagura, H.L. Xu, A. Sugawara, T. Abe, F. Satoh, K. Takeuchi, S. Ito Nongenomic vascular action of aldosterone in the glomerular microcirculation J Am Soc Nephrol 14 2003 2255 2263
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 2255-2263
-
-
Arima, S.1
Kohagura, K.2
Xu, H.L.3
Sugawara, A.4
Abe, T.5
Satoh, F.6
Takeuchi, K.7
Ito, S.8
-
24
-
-
0028079451
-
Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen
-
M. Wakisaka, M.J. Spiro, R.G. Spiro Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen Diabetes 43 1994 95 103
-
(1994)
Diabetes
, vol.43
, pp. 95-103
-
-
Wakisaka, M.1
Spiro, M.J.2
Spiro, R.G.3
-
25
-
-
0031921409
-
Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: Application in diabetic nephropathy
-
D. Ellis, K.Y. Forrest, J. Erbey, T.J. Orchard Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury application in diabetic nephropathy Clin Chem 44 1998 950 956
-
(1998)
Clin Chem
, vol.44
, pp. 950-956
-
-
Ellis, D.1
Forrest, K.Y.2
Erbey, J.3
Orchard, T.J.4
-
26
-
-
0141926500
-
Effects of the angiotensin II type 1 receptor antagonist candesartan compared with angiotensin-converting enzyme inhibitors on urinary excretions of albumin and type IV collagen in patients with diabetic nephropathy
-
A. Sato, M. Tabata, K. Hayashi, T. Saruta Effects of the angiotensin II type 1 receptor antagonist candesartan compared with angiotensin-converting enzyme inhibitors on urinary excretions of albumin and type IV collagen in patients with diabetic nephropathy Clin Exp Nephrol 7 2003 215 220
-
(2003)
Clin Exp Nephrol
, vol.7
, pp. 215-220
-
-
Sato, A.1
Tabata, M.2
Hayashi, K.3
Saruta, T.4
-
27
-
-
0036191924
-
Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels
-
R. Agarwal, S. Siva, S.R. Dunn, K. Sharma Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels Am J Kidney Dis 39 2002 486 492
-
(2002)
Am J Kidney Dis
, vol.39
, pp. 486-492
-
-
Agarwal, R.1
Siva, S.2
Dunn, S.R.3
Sharma, K.4
-
28
-
-
0028435192
-
Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli
-
M. Fukui, T. Nakamura, I. Ebihara, Y. Makita, S. Osada, Y. Tomino, H. Koide Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli J Lab Clin Med 123 1994 763 768
-
(1994)
J Lab Clin Med
, vol.123
, pp. 763-768
-
-
Fukui, M.1
Nakamura, T.2
Ebihara, I.3
Makita, Y.4
Osada, S.5
Tomino, Y.6
Koide, H.7
-
29
-
-
6444245944
-
Therapeutic benefit of spironolactone in experimental chronic cyclosporin a nephrotoxicity
-
I. Feria, I. Pichardo, P. Juarez, V. Ramirez, M.A. Gonzalez, N. Uribe, R. Garcia-Torres, F. Lopez-Casillas, G. Gamba, N.A. Bobadilla Therapeutic benefit of spironolactone in experimental chronic cyclosporin A nephrotoxicity Kidney Int 63 2003 43 52
-
(2003)
Kidney Int
, vol.63
, pp. 43-52
-
-
Feria, I.1
Pichardo, I.2
Juarez, P.3
Ramirez, V.4
Gonzalez, M.A.5
Uribe, N.6
Garcia-Torres, R.7
Lopez-Casillas, F.8
Gamba, G.9
Bobadilla, N.A.10
-
30
-
-
0037116558
-
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction. Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression
-
J. Bauersachs, M. Heck, D. Fraccarollo, S.K. Hildemann, G. Ertl, M. Wehling, M. Christ Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction. Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression J Am Coll Cardiol 39 2002 351 358
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 351-358
-
-
Bauersachs, J.1
Heck, M.2
Fraccarollo, D.3
Hildemann, S.K.4
Ertl, G.5
Wehling, M.6
Christ, M.7
-
31
-
-
0034651798
-
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failyure
-
C.A. Farquharson, A.D. Struthers Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failyure Circulation 101 2000 594 597
-
(2000)
Circulation
, vol.101
, pp. 594-597
-
-
Farquharson, C.A.1
Struthers, A.D.2
-
32
-
-
0034619571
-
Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition
-
J. Bauersachs, D. Fraccarollo, G. Ertl, N. Gretz, M. Wehling, M. Christ Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition Circulation 102 2000 2325 2328
-
(2000)
Circulation
, vol.102
, pp. 2325-2328
-
-
Bauersachs, J.1
Fraccarollo, D.2
Ertl, G.3
Gretz, N.4
Wehling, M.5
Christ, M.6
-
33
-
-
0038150601
-
Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition
-
A. Schafer, D. Fraccarollo, S. Hildemann, M. Christ, M. Eigenthaler, A. Kobsar, U. Walter, J. Bauersachs Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition Thromb Haemost 89 2003 1024 1030
-
(2003)
Thromb Haemost
, vol.89
, pp. 1024-1030
-
-
Schafer, A.1
Fraccarollo, D.2
Hildemann, S.3
Christ, M.4
Eigenthaler, M.5
Kobsar, A.6
Walter, U.7
Bauersachs, J.8
-
34
-
-
0001847493
-
Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria
-
M. Epstein, V. Buckalew Jr, F. Martinez, J. Altamirano, B. Roniker, J. Kleiman, S. Krause Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria Am J Hypertens 15 2002 24A
-
(2002)
Am J Hypertens
, vol.15
-
-
Epstein, M.1
Buckalew Jr., V.2
Martinez, F.3
Altamirano, J.4
Roniker, B.5
Kleiman, J.6
Krause, S.7
|